These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37158834)

  • 21. Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM.
    Feng S; Liang X; Li J; Wang Z; Zhang H; Dai Z; Luo P; Liu Z; Zhang J; Xiao X; Cheng Q
    Front Immunol; 2022; 13():992855. PubMed ID: 36248827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
    Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
    EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway.
    Chen H; Wen J
    Eur J Pharmacol; 2022 Apr; 921():174860. PubMed ID: 35278406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteogenomic and metabolomic characterization of human glioblastoma.
    Wang LB; Karpova A; Gritsenko MA; Kyle JE; Cao S; Li Y; Rykunov D; Colaprico A; Rothstein JH; Hong R; Stathias V; Cornwell M; Petralia F; Wu Y; Reva B; Krug K; Pugliese P; Kawaler E; Olsen LK; Liang WW; Song X; Dou Y; Wendl MC; Caravan W; Liu W; Cui Zhou D; Ji J; Tsai CF; Petyuk VA; Moon J; Ma W; Chu RK; Weitz KK; Moore RJ; Monroe ME; Zhao R; Yang X; Yoo S; Krek A; Demopoulos A; Zhu H; Wyczalkowski MA; McMichael JF; Henderson BL; Lindgren CM; Boekweg H; Lu S; Baral J; Yao L; Stratton KG; Bramer LM; Zink E; Couvillion SP; Bloodsworth KJ; Satpathy S; Sieh W; Boca SM; Schürer S; Chen F; Wiznerowicz M; Ketchum KA; Boja ES; Kinsinger CR; Robles AI; Hiltke T; Thiagarajan M; Nesvizhskii AI; Zhang B; Mani DR; Ceccarelli M; Chen XS; Cottingham SL; Li QK; Kim AH; Fenyö D; Ruggles KV; Rodriguez H; Mesri M; Payne SH; Resnick AC; Wang P; Smith RD; Iavarone A; Chheda MG; Barnholtz-Sloan JS; Rodland KD; Liu T; Ding L;
    Cancer Cell; 2021 Apr; 39(4):509-528.e20. PubMed ID: 33577785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment.
    Vo VTA; Kim S; Hua TNM; Oh J; Jeong Y
    Commun Biol; 2022 Jun; 5(1):593. PubMed ID: 35710828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
    Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
    BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteogenomic characterization and integrative analysis of glioblastoma multiforme.
    Song YC; Lu GX; Zhang HW; Zhong XM; Cong XL; Xue SB; Kong R; Li D; Chang ZY; Wang XF; Zhang YJ; Sun R; Chai L; Xie RT; Cai MX; Sun M; Mao WQ; Yang HQ; Shao YC; Fan SY; Wu TM; Xia Q; Lv ZW; Fu DA; Ma YS
    Oncotarget; 2017 Nov; 8(57):97304-97312. PubMed ID: 29228611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
    Patil V; Mahalingam K
    Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Prediction Model for Glioblastoma: A Ferroptosis-Related Gene Prediction Model and Independent External Validation.
    Chen W; Lei C; Wang Y; Guo D; Zhang S; Wang X; Zhang Z; Wang Y; Ma W
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway.
    Gao X; Guo N; Xu H; Pan T; Lei H; Yan A; Mi Y; Xu L
    Anticancer Drugs; 2020 Jan; 31(1):27-34. PubMed ID: 31490283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative proteomic analysis of global effect of LLL12 on U87 cell's proteome: An insight into the molecular mechanism of LLL12.
    Jain R; Kulkarni P; Dhali S; Rapole S; Srivastava S
    J Proteomics; 2015 Jan; 113():127-42. PubMed ID: 25286751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
    Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
    Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma.
    Zhao LX; Gong ZQ; Zhang Q; He DL; Ge RL; Meng J; Ren H; Fan YG; Wang ZY
    J Control Release; 2023 Jul; 359():12-25. PubMed ID: 37244298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma.
    Huang L; Zhang J; Gong F; Han Y; Huang X; Luo W; Cai H; Zhang F
    Front Genet; 2022; 13():927142. PubMed ID: 36226186
    [No Abstract]   [Full Text] [Related]  

  • 35. Remarkable immune and clinical value of novel ferroptosis-related genes in glioma.
    Gao X; Zhao J; Jia L; Zhang Q
    Sci Rep; 2022 Jul; 12(1):12854. PubMed ID: 35896732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-Dimensional Gene Regulation Network in Glioblastoma Ferroptosis.
    Liu M; Wang W; Zhang H; Bi J; Zhang B; Shi T; Su G; Zheng Y; Fan S; Huang X; Chen B; Song Y; Zhao Z; Shi J; Li P; Lu W; Zhang L
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rho family GTPase 1 (RND1), a novel regulator of p53, enhances ferroptosis in glioblastoma.
    Sun Q; Xu Y; Yuan F; Qi Y; Wang Y; Chen Q; Liu B
    Cell Biosci; 2022 May; 12(1):53. PubMed ID: 35505371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.
    Gimenez M; Marie SK; Oba-Shinjo S; Uno M; Izumi C; Oliveira JB; Rosa JC
    BMC Cancer; 2015 Jun; 15():481. PubMed ID: 26108672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
    Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
    J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis.
    Su X; Xie Y; Zhang J; Li M; Zhang Q; Jin G; Liu F
    Cell Death Dis; 2022 Oct; 13(10):861. PubMed ID: 36209275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.